维普期刊资源整合服务平台（V6.5）

548篇 您的检索式：作者名="moore MJ"

选中清除导出查看参考文献查看引证文献引用追踪共28页首页上一页第1页下一页末页 /28 跳转

	题名	作者	年代	出处	被引量
1	Improvements in survival and clinical benefit with gemcitabine as firstline therapy for patients with advanced pancreatic cancer: a randomized trial显示文摘	Burris HA Ⅲ Moore MJ Anderson J	1997	J Clin Oncol1997，15，6：	1
2	Improvements in sur- vival and clinical benefit with gemeitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial 显示文摘	Burris HA 3^rd Moore MJ Andersen J	1997	J Clin Oncal1997，15，：	1
3	Multi-endpoint biological monitoring of phosphine workers显示文摘	Tucker JD Moore DH Ramsey MJ	2003	Mutat Res2003，536，12：	1
4	Clinical pharmacokinetics of cyclophosphamide显示文摘	Moore MJ	1991	Clin Pharmacokinetic1991，20，：	1
5	Biodegradable polymer grafts for surgical repair of the injured spinal cord显示文摘	Friedman JA Windebank AJ Moore MJ		0，，03：	1
6	Clinical experience with transcranial Doppler ultrasonography as a confirmatory test for brain death:a retrospective analysis显示文摘	Sharma D Souter MJ Moore AE		0，，03：	1
7	Improvements in survival and clinical benefit with gemcitabine flrst-time therapy for patients with advanded pancreas cancer: Arandimized trial显示文摘	Burris HA Moore MJ Andersen J	1997	J Clin Oncol1997，15，：	1
8	Erlotinib plus gemcitabine compared with gemcitabine alone in patients with ad- vanced pancreatic cancer: a phase ⅡI trial of the National Cancer Institute of Canada Clinical Trials Group 显示文摘	MOORE MJ GOLDSTEIN D HAMM J	2007	J Clin Oncol2007，25，15：	1
9	Animal models of spinal cordinjury for evaluation of tissue engineering treatment strategies 显示文摘	Talac R Friedman JA Moore MJ	2004	Biomaterials2004，25，9：	1
10	Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial 显示文摘	Burris HA 3rd Moore MJ Andersen J	1997	J Clin Oncol1997，15，6：	1
11	Angiotensin-converting enzyme 2 is a functional receptor for the SALS coronavirus 显示文摘	Li W Moore MJ Vasilieva N Sui J Wong SK Berne MA	2003	Nature2003，，：	1
12	Pancreatic cancer:what the oncologist can offer for palliation显示文摘	Moore MJ	2002	Can J Gastroenterol2002，16，：	1
13	Advanced pancreatic carcinoma: current treatment and future challenges显示文摘	Stathis A Moore MJ	2010	Nat Rev Clin Oncol2010，7，3：	1
14	Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:A randomized trial显示文摘	Burris HA 3rd Moore MJ Andersen J	1997	J Clin Oncol1997，15，6：	1
15	Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus显示文摘	Li W Moore MJ Vasilieva N	2003	Nature2003，426，：	1
16	Phase I study of the muhidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumors 显示文摘	Le LH Moore MJ Siu LL	2005	Cancer Chemother Pharmacol2005，56，2：	1
17	Who shalt not kill? Individual differ- ences in working memory capacity, executive control, and moral judgment 显示文摘	Moore AB Clark BA Kane MJ	2008	Psychol Sci2008，19，6：	1
18	The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting显示文摘	Ramsey MJ Moore DH 2nd Briner JF	1995	Mutation Research1995，338，16：	1
19	Refractory cerebrospinal fluid rhinorrhea secondary to occult superior vena cava syndrome and benign intracranial hypertension : diagnosis and management 显示文摘	Bledsoe JM Moore E Link MJ	2009	Skull Base2009，19，4：	1
20	Erlotinib plus gemcitabine compared with gemcitabine alone in pa- tients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Tri- als Group显示文摘	Moore MJ Goldstein D Hamm J	2007	J Clin Oncol2007，25，15：	1

返回顶部每页显示：

共28页首页上一页第1页下一页末页 /28 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示